SUBKLINIK GIPOTERIOZ BILAN OG‘RIGAN BEMORLARDA UCHRAYDIGAN NEVROLOGIK BELGILARNING O‘ZIGA HOS HUSUSIYATLARI
##article.subject##:
subklinik gipoterioz, nevrologik belgilar, depressiya, stress, nevrologik testlar, kognitiv faoliyat, bosh og‘rig‘i, uyqusizlik, bosh aylanishi, emotsional buzilishlar##article.abstract##
Subklinik gipoterioz endokrin kasalliklar ichida keng tarqalgan bo‘lib, ko‘p hollarda aniqlanmay qoladi. Ushbu holatning yashirin kechishi, ayniqsa, nevrologik simptomlar orqali namoyon bo‘lishi klinik amaliyotda katta qiziqish uyg‘otmoqda. Ushbu tadqiqotda subklinik gipoterioz bilan og‘rigan 80 nafar bemor misolida, nevrologik buzilishlarning uchrash tezligi, ularning yosh va jins bo‘yicha taqsimoti o‘rganildi. Tadqiqot natijalariga ko‘ra, bemorlarning 76 % ida kamida bitta nevrologik simptom aniqlangan bo‘lib, eng ko‘p uchragan buzilishlar — bosh og‘rig‘i (48%), paresteziya (42%) va uyqusizlik (39%) bo‘lgan. Bularning aksariyati 31–50 yoshli ayollarda kuzatildi. Ushbu holat nevrologik simptomlar orqali subklinik gipoteriozni erta aniqlashda yangi yondashuvlarni ishlab chiqishga zamin yaratadi.
Библиографические ссылки
Norqobilov M.N., Saidova G.M. Qalqonsimon bez faoliyatining buzilishi va asab tizimi o‘zaro bog‘liqligi // “Tibbiyotda innovatsiyalar”, 2020, №3. – 44–47-betlar.
Xamidova N.N. Qalqonsimon bez kasalliklari va ular bilan bog‘liq nevrologik sindromlar // “Tibbiy ta’limda yangiliklar”, 2022, №2. – 39–42-betlar.
Sharipova M.T. Subklinicheskiy gipoterioz: Sovremenniy vzglyad na diagnostiku i lecheniye // “Tibbiyot va amaliyot”, 2023, №1(7). – 33–36-betlar.
American Thyroid Association. (2021). Guidelines for the treatment of hypothyroidism. https://www.thyroid.org
Bauer, M., et al. (2002). Thyroid hormones and mood disorders. International Journal of Neuropsychopharmacology, 5(2), 193–202.
Bianco, A. C., et al. (2002). Thyroid hormone regulation and brain development. Nature Reviews Endocrinology, 8(1), 22–33.
Biondi, B., Cooper, D. S. (2008). The clinical significance of subclinical thyroid dysfunction. Endocrine Reviews, 29(1), 76–131.
Canaris, G. J., et al. (2000). The Colorado thyroid disease prevalence study. Archives of Internal Medicine, 160(4), 526–534.
Demartini, B., et al. (2020). Thyroid dysfunction and headache: A review. Journal of Clinical Neuroscience, 73, 45–49.
Joffe, R. T., & Levitt, A. J. (1992). Major depression and subclinical (compensated) hypothyroidism. Psychoneuroendocrinology, 17(2–3), 215–221.
Langer, R., et al. (2018). Neurological manifestations of subclinical hypothyroidism. Endocrine Practice, 24(3), 268–275.
Larisch, R., et al. (2015). Cognitive deficits in subclinical hypothyroidism: A neuropsychological study. Thyroid, 25(12), 1317–1323.
Rizos, C. V., et al. (2011). Association of subclinical hypothyroidism with lipid profile, cardiovascular risk, and cognitive function. Hormones, 10(3), 287–294.
Surks, M. I., et al. (2004). Subclinical thyroid disease: Scientific review and guidelines for diagnosis and management. JAMA, 291(2), 228–238.
Shimomura, T., et al. (2017). Peripheral neuropathy in hypothyroid patients: Clinical and electrophysiological studies. Journal of Neurology, 264(4), 679–685.
Vanderpump, M. P. J. (2011). The epidemiology of thyroid disease. British Medical Bulletin, 99(1), 39–51.
WHO. (2022). Global prevalence of thyroid disorders and impact on population health. Geneva: World Health Organization.
Zulewski, H., et al. (1997). Subclinical hypothyroidism in hospital patients: Clinical implications. Journal of Clinical Endocrinology & Metabolism, 82(2), 359–363.
